Retaglutide is a novel GLP-1 receptor agonist currently under study for the control of metabolic disorders. This medication works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://lewysnlvu183275.full-design.com/retaglutide-a-promising-glp-1-receptor-agonist-81429612